Akalın, AyşeAyhan, FatmaGöynümer, Fikret Gökhan2023-07-262023-07-2620222458-89382564-7288https://doi.org/10.30621/jbachs.1040196https://hdl.handle.net/20.500.12684/13074Purpose: The aim of the study was to investigate the relationship between COVID-19 fear, anxiety and depression on pregnant women.Material and Methods: The cross-sectional, correlational research was conducted with 335 pregnant women from June to October 2020 at the antenatal outpatient clinics of a university hospital. Data were collected using Description Form, Fear of COVID-19 Scale, Beck Anxiety Inventory and Edinburgh Postnatal Depression Scale. Results: The Fear of COVID-19 Scale, Beck Anxiety Inventory and Edinburgh Postnatal Depression Scale average scores were 21.12 +/- 6.56, 6.39 +/- 5.48 and 8.13 +/- 9.13, respectively, indicating pregnant women' levels of COVID-19 fear were moderately high and their anxiety and depression levels were moderate. Overall, 14.0% of pregnant women had depression risk and 42.4% had symptoms of anxiety (26.3% low level, 10.4% moderate level and 5.7% high level). A positive, significant relationship was found between the COVID-19 fear level and depression (r=0.207, p<0.001), and anxiety level (r=0.135, p<0.013). COVID-19 fear and anxiety significantly predicted the risk of depression (beta=0.17, p<0.001; beta=0.43, p<0.001) and they explain 24% of the variance in depression. Conclusion: The level of COVID-19 fear increased anxiety and depression risk in pregnant women. In this context, it seems that using effective interventions to decrease of COVID-19 fear may help in reducing anxiety and risk of depression among pregnant women.en10.30621/jbachs.1040196info:eu-repo/semantics/openAccessCovid-19; Fear; Anxiety; Depression; Pandemic; Pregnant WomenSymptoms; OutcomesArticle63842850WOS:000877003600017N/A